Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES ORCHID PHARMA SUVEN LIFE SCIENCES/
ORCHID PHARMA
 
P/E (TTM) x -20.5 41.8 - View Chart
P/BV x 5.8 7.7 75.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SUVEN LIFE SCIENCES   ORCHID PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
ORCHID PHARMA
Mar-23
SUVEN LIFE SCIENCES/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs94439 21.4%   
Low Rs45273 16.5%   
Sales per share (Unadj.) Rs0.6163.1 0.4%  
Earnings per share (Unadj.) Rs-5.413.5 -40.1%  
Cash flow per share (Unadj.) Rs-5.127.0 -19.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.2168.7 10.2%  
Shares outstanding (eoy) m218.0740.82 534.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.82.2 5,124.4%   
Avg P/E ratio x-12.826.3 -48.7%  
P/CF ratio (eoy) x-13.513.2 -102.6%  
Price / Book Value ratio x4.02.1 191.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,13114,522 104.2%   
No. of employees `000NANA-   
Total wages/salary Rs m186654 28.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1356,659 2.0%  
Other income Rs m84194 43.5%   
Total revenues Rs m2206,853 3.2%   
Gross profit Rs m-1,1961,235 -96.9%  
Depreciation Rs m65548 11.9%   
Interest Rs m5329 1.6%   
Profit before tax Rs m-1,183552 -214.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m-1,183552 -214.1%  
Gross profit margin %-883.618.5 -4,764.3%  
Effective tax rate %00-   
Net profit margin %-873.58.3 -10,528.8%  
BALANCE SHEET DATA
Current assets Rs m3,4555,010 69.0%   
Current liabilities Rs m1,0503,719 28.2%   
Net working cap to sales %1,776.019.4 9,159.5%  
Current ratio x3.31.3 244.2%  
Inventory Days Days3,94857 6,883.6%  
Debtors Days Days2181,180 18.5%  
Net fixed assets Rs m1,3737,242 19.0%   
Share capital Rs m218408 53.4%   
"Free" reserves Rs m3,5356,478 54.6%   
Net worth Rs m3,7536,886 54.5%   
Long term debt Rs m01,488 0.0%   
Total assets Rs m4,82812,252 39.4%  
Interest coverage x-218.82.7 -8,167.9%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x00.5 5.2%   
Return on assets %-24.47.2 -338.9%  
Return on equity %-31.58.0 -392.8%  
Return on capital %-31.410.5 -298.0%  
Exports to sales %40.481.9 49.4%   
Imports to sales %839.837.6 2,235.8%   
Exports (fob) Rs m555,452 1.0%   
Imports (cif) Rs m1,1372,501 45.5%   
Fx inflow Rs m555,452 1.0%   
Fx outflow Rs m1,1372,726 41.7%   
Net fx Rs m-1,0822,726 -39.7%   
CASH FLOW
From Operations Rs m-1,031183 -562.5%  
From Investments Rs m-2,606-312 835.0%  
From Financial Activity Rs m3,955312 1,269.1%  
Net Cashflow Rs m317183 173.6%  

Share Holding

Indian Promoters % 69.6 69.8 99.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 18.6 3.0%  
FIIs % 0.5 4.1 13.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 30.2 100.9%  
Shareholders   74,003 36,931 200.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs Orchid Pharma Share Price Performance

Period Suven Life Sciences Orchid Pharma S&P BSE HEALTHCARE
1-Day 0.30% -0.40% 1.18%
1-Month -2.06% -14.06% -0.75%
1-Year 114.92% 173.54% 61.82%
3-Year CAGR 14.94% -23.64% 18.16%
5-Year CAGR -16.22% 184.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.